HS code: 30
To | |
Direction | |
From | |
Period | |
Selection products |
Period | Total |
---|---|
2020 | $3.3 M |
Total: | $3.3 M |
Period | Weight, tons. |
---|---|
2020 | 126 |
Total: | 126 |
Group product | 2020 | 2020 | Ch. | ∑ (2020-2020) | Ratio |
---|---|---|---|---|---|
06 3001: Glands and other organs for organo-therapeutic uses | --- | --- | --- | --- | 0% |
06 3002: Human blood; animal blood; vaccines, toxins, cultures of micro-organisms and similar products | $1 M | $1 M | 0% | $1 M | 30.8% |
06 3003: Medicaments consisting of two or more constituents, for retail sale | --- | --- | --- | --- | 0% |
06 3004: Medicaments consisting of mixed or unmixed products for retail sale | $2.3 M | $2.3 M | 0% | $2.3 M | 69.2% |
06 3005: Wadding, gauze, bandages and similar articles | --- | --- | --- | --- | 0% |
06 3006: Pharmaceutical goods specified in note 4 to this chapter | --- | --- | --- | --- | 0% |
Total: | $3.3 M | $3.3 M | $3.3 M |
№ | Country | ∑ (2020-2020) | Ratio |
---|---|---|---|
1 | Germany | $2.07 B | 19.1% |
2 | United States | $984 M | 9.1% |
3 | Italy | $800 M | 7.4% |
4 | Switzerland | $792 M | 7.3% |
5 | Ireland | $716 M | 6.6% |
6 | France | $576 M | 5.3% |
7 | India | $507 M | 4.7% |
8 | Slovenia | $318 M | 2.9% |
9 | United Kingdom | $314 M | 2.9% |
10 | Hungary | $297 M | 2.7% |
11 | Netherlands | $289 M | 2.7% |
12 | Austria | $283 M | 2.6% |
13 | China | $272 M | 2.5% |
14 | Spain | $227 M | 2.1% |
15 | Belarus | $223 M | 2.1% |
... | ... | ... | ... |
55 | Vietnam | $4.4 M | 0% |
56 | Egypt | $4.1 M | 0% |
57 | Argentina | $3.3 M | 0% |
58 | Moldova | $2.9 M | 0% |
59 | Taiwan | $1.3 M | 0% |
... | ... | ... | ... |
The total for all countries: | $10.8 B | 100% |
№ | Region | ∑ (2020-2020) | Ratio |
---|---|---|---|
1 | Moskva | $2 M | 61.8% |
2 | Moskovskaya oblast | $560 K | 17.2% |
3 | Belgorodskaya oblast | $274 K | 8.4% |
4 | Chuvashiya | $170 K | 5.2% |
5 | Kaliningradskaya oblast | $162 K | 5% |
6 | Sankt-Peterburg | $75.3 K | 2.3% |
By all regions: | $3.3 M | 100% |